As of Aug 27
| +1.51 / +1.55%|
The 28 analysts offering 12-month price forecasts for Novartis have a median target of 114.95, with a high estimate of 130.01 and a low estimate of 92.78. The median estimate represents a +16.54% increase from the last price of 98.64.
The current consensus among 31 polled investment analysts is to Buy stock in Novartis. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.